Page 229 - ENTREPRENEURSHIP Innovation and entrepreneurship
P. 229

53231_Innovation and Entrepreneurship.qxd  11/8/2002  10:50 AM  Page 222




              222                ENTREPRENEURIAL STRATEGIES

                 Meanwhile, the Hattori Company in Japan had long been making
              conventional watches for the Japanese market. It saw the opportunity
              and  went  in  for  creative  imitation,  developing  the  quartz-powered
              digital watch as the standard timepiece. By the time the Swiss had
              woken  up,  it  was  too  late.  Seiko  watches  had  become  the  world’s
              bestsellers, with the Swiss almost pushed out of the market.
                 Like being “Fustest with the Mostest,” creative imitation is a
              strategy aimed at market or industry leadership, if not at market or
              industry dominance. But it is much less risky. By the time the cre-
              ative imitator moves, the market has been established and the new
              venture has been accepted. Indeed, there is usually more demand
              for  it  than  the  original  innovator  can  easily  supply. The  market
              segmentations are known or at least knowable. By then, too, mar-
              ket research can find out what customers buy, how they buy, what
              constitutes value for them, and so on. Most of the uncertainties
              that abound when the first innovator appears have been dispelled
              or can at least be analyzed and studied. No one has to explain any
              more what a personal computer or a digital watch are and what
              they can do.
                 Of course, the original innovator may do it right the first time, thus
              closing the door to creative imitation. There is the risk of an innova-
              tor bringing out and doing the right job with vitamins as Hoffmann-
              LaRoche did, or with Nylon as did DuPont, or as Wang did with the
              word processor. But the number of entrepreneurs engaging in creative
              imitation, and their substantial success, indicates that perhaps the risk
              of the first innovator’s preempting the market by getting it right is not
              an overwhelming one.
                 Another  good  example  of  creative  imitation  is  Tylenol,  the  “non-
              aspirin aspirin.” This case shows more clearly than any other I know what
              the strategy consists of, what its requirements are, and how it works.
                 Acetaminophen  (the  substance  that  is  sold  under  the  Tylenol
              brand  name  in  the  U.S.)  had  been  used  for  many  years  as  a
              painkiller, but until recently it was available in the United States
              only by prescription. Until recently also, aspirin, the much older
              pain-killing substance, was considered perfectly safe and had the
              pain-relief  market  to  itself. Acetaminophen  is  a  less  potent  drug
              than aspirin. It is effective as a painkiller but has no anti-inflam-
              matory effect and also no effect on blood coagulation. Because of
              this it is free from the side effects, especially gastric upsets and
              stomach bleeding, which aspirin can cause, particularly if used in
   224   225   226   227   228   229   230   231   232   233   234